BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1989352)

  • 1. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
    Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.
    Freed BM; Stevens C; Zhang G; Rosano TG; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):233-9. PubMed ID: 3284070
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
    Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
    Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune signals involved in cyclosporine and methylprednisolone inhibition of A23187 ionophore induced proliferation.
    Schandene L; Denys C; Wybran J; Dupont E
    Transplant Proc; 1989 Feb; 21(1 Pt 1):82-3. PubMed ID: 2495633
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro.
    Bloemena E; van Lier RA; van Oers MH; Weinreich S; Stilma-Meinesz AP; Schellekens PT
    Transplant Proc; 1989 Feb; 21(1 Pt 1):861-5. PubMed ID: 2784907
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 12. Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation.
    Ryffel B; Woerly G; Quesniaux VF; Husi H; Foxwell BM
    Biochem Pharmacol; 1992 Mar; 43(5):953-60. PubMed ID: 1554393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of phospholipid metabolism by K+ channel blockers and inhibitors of choline transport in the Jurkat T cell line. Relationships with cell proliferation and interleukin-2 production.
    Aussel C; Cattan N; Pelassy C; Rossi B
    J Lipid Mediat; 1993 Jun; 7(2):99-113. PubMed ID: 8400120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine A on early stages of T cell activation.
    Isakov N; Scholz W; Altman A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1186-8. PubMed ID: 3493569
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of an optimal assay method for monitoring cyclosporine therapy.
    Rosano TG; Brooks CA; Dybas MT; Cramer SM; Stevens C; Freed BM
    Transplant Proc; 1990 Jun; 22(3):1125-8. PubMed ID: 2349672
    [No Abstract]   [Full Text] [Related]  

  • 19. Generation and characterization of cyclosporine metabolites produced in a hepatic microsomal system.
    Cheung F; Wong PY; Cole E; Cohen Z; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):633-6. PubMed ID: 3363659
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine inhibits macrophage-mediated antigen presentation.
    Palay DA; Cluff CW; Wentworth PA; Ziegler HK
    J Immunol; 1986 Jun; 136(12):4348-53. PubMed ID: 3486899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.